Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival

Journal of Hepatology

Volumn 53, Issue 2, 2010, Pages 291-297

  Santi, Valentina ^a   Trevisani, Franco ^a   Gramenzi, Annagiulia ^a   Grignaschi, Alice ^a   Mirici Cappa, Federica ^a   Poggio, Paolo Del ^b   Nolfo, Maria Anna Di ^c   Benvegn, Luisa ^d   Farinati, Fabio ^d   Zoli, Marco ^a   Giannini, Edoardo Giovanni ^e   Borzio, Franco ^f   Caturelli, Eugenio ^g   Chiaramonte, Maria ^h   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b TREVIGLIO HOSPITAL   (Italy)

^c BOLOGNINI HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g BELCOLLE HOSPITAL   (Italy)

^h SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

Cancer stage; Cirrhosis; Diagnosis; Hepatocellular carcinoma; Surveillance interval; Survival

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; ECHOGRAPHY; HEALTH SURVEY; ITALY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; HUMANS; ITALY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; SURVIVAL RATE;

EID: 77955306863     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.03.010     Document Type: Article

References (39)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics 2002 CA Cancer J Clin 55 2005 74 108
2. A. Sangiovanni, E. Del Ninno, P. Fasani, C. De Fazio, G. Ronchi, and R. Romeo Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 2004 1005 1014
3. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
4. G. Fattovich, T. Stroffolini, I. Zagni, and F. Donato Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
5. H. Tsukuma, T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, and T. Kitamura Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801 (Pubitemid 23174709)
6. K. Kiyosawa, T. Unemura, T. Ichijo, A. Matsumoto, K. Yoshizawa, and A. Gad Hepatocellular carcinoma: recent trends in Japan Gastroenterology 127 2004 S17 S26
7. B.H. Zhang, B.H. Yang, and Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 127 2004 35 50
8. M.F. Yuen, C.C. Cheng, I.J. Lauder, S.K. Lam, C.G. Ooi, and C.L. Lai Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience Hepatology 31 2000 330 335
9. L. Bolondi, S. Sofia, S. Siringo, S. Gaiani, A. Casali, and G. Zironi Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis Gut 48 2001 251 259
10. F. Trevisani, S. De Notariis, G. Rapaccini, F. Farinati, L. Benvegn, and M. Zoli Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) Am J Gastroenterol 97 2002 734 744
11. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
12. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of the Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
13. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 2008 S20 S37
14. M. Kojiro, and T. Roskams Early hepatocellular carcinoma and dysplastic nodules Semin Liver Dis 25 2005 133 142
15. I. Ikai, S. Arii, M. Kojiro, T. Ichida, M. Makuuchi, and Y. Matsuyama Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey Cancer 101 2004 796 802
16. G.T. Huang, P.H. Lee, Y.M. Tsang, M.Y. Lai, P.M. Yang, and R.H. Hu Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma. A prospective study Ann Surg 242 2005 36 42
17. S.M. Lin, C.J. Lin, C.C. Lin, C.W. Hsu, and Y.C. Chen Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less Gut 54 2005 1151 1156
18. R.A. Lencioni, H.P. Allgaier, D. Cioni, M. Olschewski, P. Deibert, and L. Crocetti Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 2003 235 240
19. R.T. Poon, S.T. Fan, C.M. Lo, C.L. Liu, and J. Wong Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival Ann Surg 245 2007 51 58
20. P. Fasani, A. Sangiovanni, C. De Fazio, M. Borzio, S. Bruno, and G. Ronchi High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors Hepatology 29 1999 1704 1707
21. F. Trevisani, G. Magini, V. Santi, A.M. Morselli-Labate, M.C. Cantarini, and M.A. Di Nolfo Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance Am J Gastroenterol 102 2007 1022 1231
22. F. Trevisani, V. Santi, A. Gramenzi, M.A. Di Nolfo, P. Del Poggio, and L. Benvegn Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol 102 2007 2448 2457 (Pubitemid 47631760)
23. S. Pascual, J. Irurzun, P. Zapater, J. Such, L. Sempere, and F. Carnicer Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice Liver Int 28 2008 682 689
24. D.Y. Kim, K.H. Han, S.A. Ahn, Y.H. Pik, K.S. Lee, and C.Y. Chon Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual surveillance (Korean experience) Hepatology 46 Suppl. 2007 403A [abstract]
25. Commissione "Epatocarcinoma" dell'Associazione Italiana per lo Studio del Fegato. Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia. Bologna: Tipografia Moderna; 1998.
26. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis N Engl J Med 334 1996 693 699
27. P.C. Adams, M.J. Arthur, T.D. Boyer, L.D. DeLeve, A.M. Di Bisceglie, and M. Hall Screening in liver disease: report of an AASLD clinical workshop Hepatology 39 2004 1204 1212
28. M.A. Schwartz Biomathematical approach to clinical tumor growth Cancer 14 1961 1272 1294
29. J.C. Scheu, J.L. Sung, D.S. Chen, P.M. Yang, M.Y. Lai, and C.S. Lee Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Gastroenterology 89 1985 259 266
30. N. Chalasani, J.C. Horlander Sr., A. Said, H. Hoen, K.K. Kopecky, and S.M. Stockberger Jr. Screening for hepatocellular carcinoma in patients with advanced cirrhosis Am J Gastroenterol 94 1999 2988 2993
31. F.P. Sarasin, E. Giostra, and A. Hadengue Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis Am J Med 101 1996 422 434
32. K.L. Andersson, J.A. Salomon, S.J. Goldie, and R.T. Chung Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis Clin Gastroenterol Hepatol 6 2008 1418 1424
33. Trinchet J, Beaugrand M, for GRETCH. A randomised trial comparing 3-month vs. 6-month screening for HCC by ultrasonography in cirrhosis [abstract]. Book of Abstract-International Liver Cancer Association (ILCA), 2007.
34. E. Ando, R. Kuromatsu, M. Tanaka, A. Takada, N. Fukushima, and S. Sumia Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease J Clin Gastroenterol 40 2006 942 948
35. H. Tanaka, K. Nouso, H. Kobashi, Y. Kobayashi, S. Nakamura, and Y. Miyake Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival Liver Int 26 2006 543 551
36. K. Nouso, H. Tanaka, S. Uematsu, K. Shiraga, R. Okamoto, and H. Onishi Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances J Gastroenterol Hepatol 23 2008 437 444
37. E.G. Giannini, G. Bodini, M. Corbo, V. Savarino, D. Risso, and M.A. Di Nolfo Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma Aliment Pharmacol Ther 31 2010 493 501
38. F. Trevisani, and V. Santi Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of Nostradamus Dig Liver Dis 41 2009 382 384
39. A. Singal, M.L. Volk, A. Waljee, R. Salgia, P. Higgins, and M.A. Rogers Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis Aliment Pharmacol Ther 30 2009 37 47